Patent Assignment
Reel/Frame 054299/0756
Assignment of Assignor's Interest
Recorded: 2020-11-04
Pages: 26
Assignors
YU, YING
Executed: 2016-05-23
DENKER, ANDREW EVAN
Executed: 2016-05-20
SADEKOVA, SVETLANA
Executed: 2016-05-23
PHAN, UYEN TRUONG
Executed: 2016-05-23
KASTELEIN, ROBERT A.
Executed: 2016-05-23
KAUFMAN, DAVID ROSS
Executed: 2016-05-17
COFFMAN, ROBERT L.
Executed: 2018-05-31
GUIDUCCI, CRISTIANA
Executed: 2018-05-31
JANSSEN, ROBERT S.
Executed: 2018-05-31
Assignees
MERCK SHARP & DOHME CORP.
126 EAST LINCOLN AVENUE, RAHWAY, NEW JERSEY, 07065
DYNAVAX TECHNOLOGIES CORPORATION
2929 SEVENTH STREET, SUITE 100, BERKELEY, CALIFORNIA, 94710
Covered Property
(1)
Combination of a Pd-1 Antagonist and Cpg-C Type Oligonucleotide for Treating Cancer
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 15, 2020
From: DYNAVAX TECHNOLOGIES CORPORATION
To: SUREFIRE MEDICAL, INC. D/B/A TRISALUS LIFE SCIENCES
Reel/Frame 054646/0615 →
Change of Name
Oct 27, 2021
From: SUREFIRE MEDICAL, INC. D/B/A TRISALUS LIFE SCIENCES
To: TRISALUS LIFE SCIENCES, INC.
Reel/Frame 057943/0686 →
Merger
Jan 3, 2023
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 062264/0846 →
Security Interest
Apr 30, 2024
From: TRISALUS LIFE SCIENCES, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP
Reel/Frame 067274/0733 →